Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)

Title
Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)
Authors
Keywords
-
Journal
ONCOLOGY REPORTS
Volume 23, Issue 5, Pages -
Publisher
Spandidos Publications
Online
2010-03-31
DOI
10.3892/or_00000749

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started